Pfizer, Medivation to discontinue Dimebon development following late-stage trial results

Pfizer, Medivation announce results of phase-3 trial in Alzheimer's patients
January 17, 2012
A late-stage clinical trial to evaluate a drug in Alzheimer's disease patients came up short, the drug's developers said Tuesday.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>

Comments

Post a Comment
Jan 18, 2012 - 08:44
starson says:

I was fascinated to discover

I was fascinated to discover that there's been research on saffron versus Aricept (donepezil). Check it out: http://nutritionfacts.org/videos/saffron-versus-aricept/. (noncommercial, science-based site) According to the findings, saffron works just as well (which isn't all that well, though better than placebo). And without the side effects.

© 2012 Drug Store News. All Rights Reserved.